{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:17:41Z","timestamp":1786663061179,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1097\/mcg.0b013e318182015a","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T08:38:17Z","timestamp":1242895097000},"page":"482-488","source":"Crossref","is-referenced-by-count":56,"title":["Prognostic Values of \u03b1-fetoprotein and Protein Induced by Vitamin K Absence or Antagonist-II in Hepatitis B Virus-related Hepatocellular Carcinoma"],"prefix":"10.1097","volume":"43","author":[{"given":"Hyoung Su","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Sun","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woon Geon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Heon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hak Yang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myoung Kuk","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210305","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1053\/j.gastro.2004.09.011","article-title":"Primary liver cancer: worldwide incidence and trends","volume":"127","author":"Bosch","year":"2004","journal-title":"Gastroenterology"},{"key":"R2-17-20210305","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.1440","article-title":"Estimating the world cancer burden: Globocan 2000","volume":"94","author":"Parkin","year":"2001","journal-title":"Int J Cancer"},{"key":"R3-17-20210305","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJM199903113401001","article-title":"Rising incidence of hepatocellular carcinoma in the United States","volume":"340","author":"El-Serag","year":"1999","journal-title":"N Engl J Med"},{"key":"R4-17-20210305","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0168-8278(98)80262-6","article-title":"Time trends and age-period-cohort effects on the incidence of primary liver cancer in a well-defined French population: 1976-1995","volume":"29","author":"Benhamiche","year":"1998","journal-title":"J Hepatol"},{"key":"R5-17-20210305","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bpg.2004.10.003","article-title":"Serological markers of liver cancer","volume":"19","author":"Yuen","year":"2005","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R6-17-20210305","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1046\/j.1440-1746.2002.02806.x","article-title":"Clinicopathologic features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein-L3 and seronegative for des-gamma-carboxy prothrombin in comparison with those seropositive for des-gamma-carboxy prothrombin alone","volume":"17","author":"Okuda","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"R7-17-20210305","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1046\/j.1440-1746.2001.02610.x","article-title":"Comparison of clinicopathological features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein alone and those seropositive for des-gamma-carboxy prothrombin alone","volume":"16","author":"Okuda","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"R8-17-20210305","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1542-3565(05)00855-4","article-title":"Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma","volume":"4","author":"Toyoda","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R9-17-20210305","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1056\/NEJM198405313102204","article-title":"Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma","volume":"310","author":"Liebman","year":"1984","journal-title":"N Engl J Med"},{"key":"R10-17-20210305","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0168-8278(87)80546-9","article-title":"Production of abnormal prothrombin (des-gamma-carboxy prothrombin) by hepatocellular carcinoma. A clinical and experimental study","volume":"4","author":"Okuda","year":"1987","journal-title":"J Hepatol"},{"key":"R11-17-20210305","first-page":"235","article-title":"Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study","volume":"49","author":"Ikoma","year":"2002","journal-title":"Hepatogastroenterology"},{"key":"R12-17-20210305","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<544::AID-CNCR8>3.0.CO;2-F","article-title":"Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma","volume":"88","author":"Okuda","year":"2000","journal-title":"Cancer"},{"key":"R13-17-20210305","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/(SICI)1097-0142(19990215)85:4<812::AID-CNCR8>3.0.CO;2-O","article-title":"Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity","volume":"85","author":"Okuda","year":"1999","journal-title":"Cancer"},{"key":"R14-17-20210305","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1643::AID-CNCR8>3.0.CO;2-B","article-title":"The usefulness of determining des-gamma-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma","volume":"82","author":"Mita","year":"1998","journal-title":"Cancer"},{"key":"R15-17-20210305","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1572-0241.1999.00930.x","article-title":"Serum des-gamma-carboxy prothrombin levels determined by a new generation of sensitive immunoassays in patients with small-sized hepatocellular carcinoma","volume":"94","author":"Nomura","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"R16-17-20210305","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/BF01296626","article-title":"Clinical usefulness of des-gamma-carboxy prothrombin assay in early diagnosis of hepatocellular carcinoma","volume":"36","author":"Fujiyama","year":"1991","journal-title":"Dig Dis Sci"},{"key":"R17-17-20210305","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1007\/BF01299891","article-title":"Clinical evaluation of plasma des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes","volume":"38","author":"Kasahara","year":"1993","journal-title":"Dig Dis Sci"},{"key":"R18-17-20210305","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.1840110321","article-title":"Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma","volume":"11","author":"Tsai","year":"1990","journal-title":"Hepatology"},{"key":"R19-17-20210305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1746.1992.tb00925.x","article-title":"Plasma abnormal prothrombin (PIVKA-II): a new and reliable marker for the detection of hepatocellular carcinoma","volume":"7","author":"Takikawa","year":"1992","journal-title":"J Gastroenterol Hepatol"},{"key":"R20-17-20210305","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1046\/j.1365-2168.1999.01185.x","article-title":"Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma","volume":"86","author":"Imamura","year":"1999","journal-title":"Br J Surg"},{"key":"R21-17-20210305","first-page":"25","article-title":"Des-gamma-carboxyprothrombin expression in cancer and\/or non-cancer liver tissues: association with survival of patients with resectable hepatocellular carcinoma","volume":"13","author":"Tang","year":"2005","journal-title":"Oncol Rep"},{"key":"R22-17-20210305","first-page":"2222","article-title":"Clinical significance of abnormal prothrombin (DCP) in relation to postoperative survival and prognosis in patients with hepatocellular carcinoma","volume":"89","author":"Inoue","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"R23-17-20210305","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0168-8278(00)80072-0","article-title":"Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection","volume":"32","author":"Khan","year":"2000","journal-title":"J Hepatol"},{"key":"R24-17-20210305","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/1097-0142(20010201)91:3<561::AID-CNCR1035>3.0.CO;2-N","article-title":"Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients","volume":"91","author":"Koike","year":"2001","journal-title":"Cancer"},{"key":"R25-17-20210305","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1111\/j.1572-0241.2006.00681.x","article-title":"Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size","volume":"101","author":"Nakamura","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R26-17-20210305","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1002\/cncr.11839","article-title":"The des-gamma-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma","volume":"98","author":"Nagaoka","year":"2003","journal-title":"Cancer"},{"key":"R27-17-20210305","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/(SICI)1097-0142(20000401)88:7<1557::AID-CNCR9>3.0.CO;2-G","article-title":"Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-gamma-carboxy prothrombin and low serum alpha-fetoprotein","volume":"88","author":"Hamamura","year":"2000","journal-title":"Cancer"},{"key":"R28-17-20210305","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s00268-004-7205-y","article-title":"Positive status of alpha-fetoprotein and des-gamma-carboxy prothrombin: important prognostic factor for recurrent hepatocellular carcinoma","volume":"28","author":"Kaibori","year":"2004","journal-title":"World J Surg"},{"key":"R29-17-20210305","first-page":"2072","article-title":"Clinical characteristics among patients with hepatocellular carcinoma according to the serum levels of alpha-fetoprotein and des-y-carboxy prothrombin","volume":"50","author":"Dohmen","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"R30-17-20210305","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1572-0241.2006.00364.x","article-title":"Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma","volume":"101","author":"Cantarini","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R32-17-20210305","first-page":"2442","article-title":"A comparison of hepatocellular carcinoma associated with HBV or HCV infection","volume":"46","author":"Tanabe","year":"1999","journal-title":"Hepatogastroenterology"},{"key":"R33-17-20210305","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMe048237","article-title":"Prevention of hepatocellular carcinoma","volume":"351","author":"Wands","year":"2004","journal-title":"N Engl J Med"},{"key":"R34-17-20210305","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2893.2004.00521.x","article-title":"Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis","volume":"11","author":"Anzola","year":"2004","journal-title":"J Viral Hepat"},{"key":"R35-17-20210305","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/j.1572-0241.2007.01100.x","article-title":"Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance","volume":"102","author":"Trevisani","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R36-17-20210305","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004836-200905000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:54:56Z","timestamp":1786038896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004836-200905000-00017"}},"subtitle":["A Prospective Study"],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0b013e318182015a","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}